Search

The artificial intelligence (AI) technology with supreme capacity of big data integration and management have been used in digital diagnosis and clinical treatment,which have greatly facilitated the development of clinical oncology and precision medicine. AI technology is far superior to human beings in big data integration and analysis, so has been widely applied in pathological image analysis, molecular marker discovery, clinical decision support, drug discovery and recommendation and so on. In recent years, many remarkable achievements have been made in the field. This review discussed the latest applications of AI-assisted precision cancer diagnosis and treatment, highlighted emerging challenges, and predicted the development trend in the future.

Objective: To solve the problem that the thickness and tightness of the rhizopus brick by traditional mechanical stamping JIUQU starter press were different, so as to achieve the effect of manual trampling on the liquor. Methods: Through the analysis of the existing JIUQU starter press machine in the distillery, the transmission mechanism of the mechanical stamping JIUQU starter press machine was optimized, the original crank connecting rod mechanism that controlled the movement of the JIUQU starter die was replaced by the groove cam mechanism, and the cam profile curve was inversely calculated according to the relationship between the JIUQU starter press force and the compression amount of the JIUQU starter press material, and the eleventh degree polynomial cam profile curve that conforms to the compression deformation of the JIUQU starter press material was constructed. Results: Compared with the original mechanism, it can reduce the movement time of non working stage by 75.09% and increase the movement time of working stage by 192.60%. Conclusion: After the optimization design, the JIUQU starter press force is matched with the compression amount of JIUQU starter and the effect of the optimal of best JIUQU starter press is achieved.

Clonal integration is an important ecological advantage of clonal plants. To ask whether clonal integration can help invasive plants escape space limitations, we tested the hypothesis that it can promote the growth of apical ramets when their connected basal ramets grow in limited space. We conducted a greenhouse experiment on the common perennial herb Hydrocotyle vulgaris. Clonal fragments consisting of pairs of connected ramets grew with basal ramets in three different sizes of pots (small, medium, and large) and apical ramets in large pots, and the connection between ramets was either severed or left intact. Pot size significantly affected the growth of basal ramets such that the biomass, number of leaves and flowers, and stolon length were in general greater in medium pots than in large and small pots when stolons were intact and were greater in medium and large pots than in small pots when stolons were severed. Furthermore, pot size interacted with severance to affect the performance of H. vulgaris. When the basal ramets grew in small pots, the intact stolon resulted in a significant promotion of apical ramet growth, but such positive effect was not found when the basal ramets grew in medium and large pots. Our results suggest that H. vulgaris is able to promote the growth of apical ramets to occupy the surrounding areas through clonal integration when the space where basal ramets grow is limited. [ABSTRACT FROM AUTHOR]

Objective: To investigate the efficacy and prognosis of chemotherapy regimen containing Bruton's tyrosine kinase (BTK) inhibitor in the treatment of relapsed/refractory mantle cell lymphoma (R/R MCL)., Methods: The clinical data of 134 patients with R/R MCL were collected and analyzed retrospectively. The clinical characteristics of patients and effect of chemotherapy regimen on efficacy, overall survival (OS) and progression-free survival (PFS) were observed., Results: The median age of the patients was 58(56-61) years old, and male to female ratio was about 2.9∶1. Patients with Ann Arbor stage III-IV accounted for 77.6%, extranodal involvement > 2 for 43.3%, bone marrow involvement for 60.4%, gastrointestinal involvement for 24.6%, and hepatosplenomegaly for 38.1%. The median follow-up time was 30 (2-103) months, overall response rate (ORR) was 41.8%, 3-year PFS was not reached, and 3-year and 5-year OS rate was 62.7% and 53.8%, respectively. The ORR of BTK inhibitor group was 56.9%, which was higher than 32.5% of non-BTK inhibitor group ( P =0.006). The difference was statistically significant in PFS between the two groups ( P =0.002), but was not in OS (P>0.05). The difference was statistically significant in OS between classical and special morphology ( P < 0.001), but was not in PFS ( P >0.05). Ki-67 was an influencing factor for OS and PFS. Multivariate analysis showed that Ki-67, B symptoms, MIPI score, and Ann Arbor stage were independent prognostic factors affecting patients' OS. The second-line treatment regimen was an independent prognostic factor affecting patients' PFS., Conclusions: The chemotherapy regimen containing BTK inhibitors can effectively improve the efficacy and prolong the PFS of R/R MCL patients. Ki-67, B symptoms, MIPI score, and Ann Arbor stage are independent prognostic factors for R/R MCL patients.